Skip to main content
. 2022 Nov 10;12:19218. doi: 10.1038/s41598-022-23960-w

Table 1.

Demographic and clinical characteristics at presentation of the study cohort.

Follow-up Group Aa Follow-up Group Bb p-value
n = 35 (42.7%) n = 47 (57.3%)
Gender
Boys, n (%) 24 (68.6) 20 (42.6) 0.02
Girls, n (%) 11 (31.4) 27 (57.4)
Age (years)
Mean ± SD (range) 10.19 ± 3.78 (0.11–16.7) 11.31 ± 4.33 (1.2–17.5) 0.22
Pubertal state c
Prepuberal, n (%) 19 (54.3) 20 (42.6) 0.29
Pubertal, n (%) 16 (45.7) 27 (57.4)
Ethnic origin
Jewish, n (%) 27 (77.2) 33 (70.2) 0.48
Arab, n (%) 8 (22.8) 14 (29.8)
Obesity d
n (%) 18 (51.4) 19 (40.4) 0.32
Symptoms
Headache, n (%) 28 (80) 39 (83) 0.73
Visual disturbance, n (%) 17 (48.5) 32 (68.1) 0.07
Nausea/ vomiting, n (%) 8 (22.8) 12 (25.5) 0.78
Tinnitus, n (%) 2 (5.7) 1 (2.1) 0.39
Asymptomatic, n (%) 2 (5.7) 2 (4.2) 0.76
Clinical signs
CN VI palsy, n (%) 6 (17.1) 15 (32) 0.12
Papilledema, n (%) 32 (91.4) 38 (80.8) 0.18
CSF opening pressure, mean ± SD (range), cm of water 39.7 ± 9.2 (28–60) 39 ± 7.9 (28–55) 0.74

SD, standard deviation; CN, cranial nerve; NA not available.

aContinuous follow-up in tertiary center; bFollow-up in community clinics or no follow-up at all; cGirls over the age of 10 years and boys over the age of 11 years; dWeight percentile ≥ 95%, data was not available for 5 children.

HHS Vulnerability Disclosure